	US 11,918,552 B2
	N-acetylcysteine for use as antibacterial agent
Gian Maria Rossolini, Siena (IT); Lucia Pallecchi, Colle di Val d'Elsa (IT); and Francesco Sergio, Piacenza (IT)
Assigned to Zambon S.P.A., Bresso (IT)
Filed by Zambon S.P.A., Bresso (IT)
Filed on Dec. 28, 2020, as Appl. No. 17/134,719.
Application 17/134,719 is a division of application No. 16/468,716, abandoned, previously published as PCT/EP2017/082512, filed on Dec. 13, 2017.
Claims priority of application No. 16204412 (EP), filed on Dec. 15, 2016.
Prior Publication US 2021/0113508 A1, Apr. 22, 2021
Int. Cl. A61K 31/197 (2006.01); A61P 31/04 (2006.01)

CPC A61K 31/197 (2013.01) [A61P 31/04 (2018.01)]

9 Claims

1. A method of preventing lung colonization by Burkholderia cepacian complex (BCC) in individuals affected by chronic diseases impacting lower respiratory system by inhibiting biofilm formation caused by said BCC, said method comprising

administering a pharmaceutically effective amount of a pharmaceutical composition comprising NAC to said individuals,

wherein said pharmaceutical composition is administered orally, parenterally, by inhalation, nebulization or instillation.